• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR GRAFTMASTER; CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR GRAFTMASTER; CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1012581-26
Medical Device Problem Code Failure to Advance (2524)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 10/18/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Exemption number e2019001.The device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2019, the patient presented with a vein graft to the right coronary artery (rca) perforation.A 3.5x26mm graftmaster (gm) stent delivery system (sds) failed to cross the lesion.During device removal from the anatomy, the back end of the stent delivery system touched a non-sterile filed.The device was discarded and another device was used in replacement.A 3.5x16mm and a 3.5x26mm gm stent were implanted, sealing the perforation at each implantation site.Per physician, the gm devices did not cause or contribute to complications or adverse events.There was no device malfunction reported with the implanted gm stents.No additional information was provided regarding this issue.
 
Event or Problem Description
Subsequent to the initial medwatch report, the additional information was obtained: the first 3.5x26mm graftmaster (gm) stent delivery system (sds) had failed to cross a lesion due to anatomy.
 
Additional Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation was unable to determine a conclusive cause for the reported failure to advance; however, the subsequent treatment appears to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTMASTER
Common Device Name
CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9317019
Report Number2024168-2019-13516
Device Sequence Number2373384
Product Code MAF
UDI-Device Identifier08717648176418
UDI-Public08717648176418
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
H000001
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2019
Device Catalogue Number1012581-26
Device Lot Number8011741
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/25/2019
Supplement Date Received by Manufacturer12/06/2019
Initial Report FDA Received Date11/13/2019
Supplement Report FDA Received Date12/20/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
-
-